AstraZeneca to supply 2M doses of COVID-19 vaccine every week in UK

 

• 2M doses of COVID-19 vaccine developed by AstraZeneca (NASDAQ:AZN) and the Oxford University will reach the U.K. every week by mid-January, The Times reports, citing an unnamed member of the Oxford-AstraZeneca team.
• “The plan is then to build it up fairly rapidly - by the third week of January we should get to two million a week,” the report said.
• The U.K. government has ordered 100M doses of the Oxford-AstraZeneca COVID-19 vaccine, more than 40M and 5M ordered from Pfizer (NYSE:PFE)/ BioNTech (NASDAQ:BNTX), and Moderna (NASDAQ:MRNA), respectively.
• Meanwhile, amid the raging infection in the country, the U.K government has updated the COVID-19 vaccination guidelines allowing the second shot of both the BioNTech/Pfizer and Oxford/AstraZeneca vaccines to be delivered as much as three months after the first.
• However, Pfizer, whose vaccine won the approval in early December, has questioned the move, reiterating the importance of the 21-day gap recommended for the booster dose.
• Early this week, the Oxford-AstraZeneca COVID-19 vaccine that uses a replication-deficient chimpanzee viral vector was granted emergency approval in the U.K. with a delay of 12 weeks recommended between the two-dose regimen.
• https://seekingalpha.com/news/3648177-astrazeneca-to-supply-2m-doses-of-covidminus-19-vaccine-every-week-in-u-k-times